Seasonal malaria chemoprevention (SMC) is a highly effective intervention to prevent malaria in those most vulnerable to the disease's effects. It involves administering monthly doses of antimalarial drugs to children aged 3-59 months during peak malaria transmission season.
Malaria Consortium is a leading implementer of SMC. Our SMC programme in Burkina Faso, Chad, Mozambique, Nigeria, Togo and Uganda is top rated by GiveWell for its cost-effectiveness.
We strive to continuously improve quality of SMC implementation and to contribute to the evidence base through monitoring and evaluation (M&E) and research. Find out about our work on SMC implementation in our SMC newsletter.